• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五种头孢霉素在药物浓度降低时对三种革兰氏阴性杆菌细胞的杀菌及形态学比较效应

Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.

作者信息

Goi H, Watanabe T, Miyauchi K, Kazuno Y, Inouye S

出版信息

Drugs Exp Clin Res. 1985;11(11):771-80.

PMID:3915467
Abstract

The bactericidal and morphological effects under drug-decreasing conditions of cefminox (MT-141), cefoxitin, cefmetazole, cefotetan and latamoxef were compared on Klebsiella pneumoniae PCl-602, Escherichia coli No. 29 and Serratia marcescens No. 1 cells. A new drug-decreasing method was developed by the use of an antibiotic removal device. Cefminox displayed an earlier onset and a higher rate of bactericidal action than the other cephamycins against the test organisms, although the minimum inhibitory concentrations of cefminox were similar to or higher than those of the other drugs. Morphologically, cefminox caused rapid lysis of the cells without filamentation, whereas the reference cephamycins caused mainly elongation of the cells under the test conditions. Frequent formation of multiple bulges on cells exposed to cefminox was observed in an isotonic medium.

摘要

比较了头孢米诺(MT - 141)、头孢西丁、头孢美唑、头孢替坦和拉氧头孢在药物减量条件下对肺炎克雷伯菌PCl - 602、大肠杆菌29号和粘质沙雷氏菌1号细胞的杀菌和形态学效应。通过使用抗生素去除装置开发了一种新的药物减量方法。尽管头孢米诺的最低抑菌浓度与其他药物相似或更高,但与其他头孢霉素相比,头孢米诺对受试菌表现出更早的起效时间和更高的杀菌作用速率。在形态学上,头孢米诺可使细胞迅速裂解而不形成丝状体,而在测试条件下,对照头孢霉素主要导致细胞伸长。在等渗培养基中观察到,暴露于头孢米诺的细胞频繁形成多个凸起。

相似文献

1
Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.五种头孢霉素在药物浓度降低时对三种革兰氏阴性杆菌细胞的杀菌及形态学比较效应
Drugs Exp Clin Res. 1985;11(11):771-80.
2
Pharmacology of cefminox, a new bactericidal cephamycin.新型杀菌性头孢霉素美诺沙星的药理学
Drugs Exp Clin Res. 1990;16(9):461-7.
3
[Morphological alterations in Escherichia coli and Serratia marcescens induced by cefotetan (author's transl)].头孢替坦对大肠杆菌和粘质沙雷氏菌的形态学改变(作者译)
Jpn J Antibiot. 1982 Mar;35(3):850-5.
4
[In vitro bactericidal effect of cefotetan-aminoside combinations].头孢替坦-氨基糖苷类联合用药的体外杀菌作用
Pathol Biol (Paris). 1988 May;36(5):361-5.
5
Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.头孢米诺(MT-141)、头孢噻肟和头孢哌酮对革兰氏阴性菌的体外和体内活性比较
Drugs Exp Clin Res. 1985;11(11):781-6.
6
Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.头孢唑林、头孢西丁和头孢美唑对大肠杆菌和肺炎克雷伯菌的杀菌活性。
Chemotherapy. 1982;28(1):18-25. doi: 10.1159/000238056.
7
Bacteriolytic combination effect of cefminox and piperacillin evaluated by turbidimetry.用比浊法评估头孢米诺与哌拉西林的溶菌联合效应。
Drugs Exp Clin Res. 1989;15(9):397-407.
8
[Timed bacteriostatic and bactericidal activities of latamoxef against clinical strains of gram-negative bacteria].[拉氧头孢对革兰氏阴性菌临床菌株的定时抑菌和杀菌活性]
Jpn J Antibiot. 1983 Jan;36(1):16-21.
9
[Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
Jpn J Antibiot. 1985 Jan;38(1):27-30.
10
The bacteriolytic action of MT-141, a new cephamycin antibiotic, on gram-negative bacteria.新型头孢霉素抗生素MT-141对革兰氏阴性菌的溶菌作用。
J Antimicrob Chemother. 1985 Feb;15(2):159-71. doi: 10.1093/jac/15.2.159.

引用本文的文献

1
In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.头孢米诺对厌氧菌的体外活性与其他九种化合物的比较。
Antimicrob Agents Chemother. 1998 Mar;42(3):495-501. doi: 10.1128/AAC.42.3.495.
2
Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime.原子力显微镜:应用于研究大肠杆菌在暴露于头孢地嗪前后的形态。
Antimicrob Agents Chemother. 1998 Jan;42(1):18-22. doi: 10.1128/AAC.42.1.18.